ALFA Finder| Margins | Q1FY27 Gross Margin 28% vs 22% YoY; EBITDA Margin 5.7%. |
|---|---|
| Demand visibility | Strong domestic demand; deeper B2C penetration. |
Growth
Revenue for Q1 FY27 declined 11% YoY compared to Q1 FY26; PAT declined 38% YoY.
Outlook
Expanding Barwasni facility for dry flowable plant; focusing on geographic diversification into Brazil and Africa.
Risks
Company faces seasonality risks and heavy dependence on Crop Protection segment (87% of revenue).
Last quarter's promises, checked
Delivered
- Barwasni expansion status → Construction phase over (= BEAT)
- Debt-equity ratio reduction → 0.8% to 0.4% (= BEAT)
- FY26 Revenue Growth → 19% YoY (= BEAT)
Partly delivered
- Specialty product revenue mix → 16% delivered (= PARTIAL)
Missed
- Unit 5 launch Q1 FY27 → Delayed to Q3/Q4 FY27 (= MISS)
- Q1 FY27 Revenue → 11% YoY decline vs 'prepared' outlook (= MISS)
- Q1 FY27 PAT → 38% YoY decline (= MISS)
Investor Presentation filed with BSE, NSE: IGCL. Summary written with AI assistance from the document.
Indogulf Cropsciences Ltd: key numbers
- Share price
- ₹63.10
- Market cap
- ₹398.9 Cr
- Revenue (annual)
- ₹704.6 Cr
- Net profit (annual)
- ₹40.03 Cr
- P/E (TTM)
- 9.2×Sector 35.5×
- Promoter holding
- 69.05%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indogulf Cropsciences Ltd
All →Indogulf Cropsciences Earnings Call Transcript: Key Takeaways
Q2 revenue +3% to ₹255.8 Cr; EBITDA +27%, margin 16% (13%) on mix and cost cuts. H1 revenue -3%, negative operating cash flow, inventory elevated.
Indogulf Cropsciences Results Update
Indogulf Cropsciences reported Q2 FY27 EBITDA of ₹41 Cr (up 27%) and PAT of ₹26 Cr (up 24%). Margin expanded 300 bps to 16% on favourable product mix.
Indogulf Cropsciences Other Announcement
Indogulf Cropsciences filed its Monitoring Agency Report for the quarter ended September 30, 2026, covering IPO proceeds of Rs 200 crore. The report states no deviation from the objects of the issue.
Indogulf Cropsciences Investor Presentation: Key Takeaways
Q2 FY27 revenue up 3% YoY to INR 2,558 Mn; EBITDA up 27% to 406 Mn (15.9% margin); PAT up 24% to 257 Mn. H1 revenue down 3%.
Indogulf Cropsciences Q2 FY27 Results: Net Profit ₹25.7 Cr, Up 24.2% YoY
Indogulf Cropsciences Ltd reported revenue from operations of ₹255.8 Cr (+3.0% YoY) and net profit of ₹25.7 Cr (+24.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹25.7 Cr · +24.2% YoY
Indogulf Cropsciences Board Meeting Date
Indogulf Cropsciences will hold a board meeting on 2 November 2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. The trading window closes from 1 October 2026.